Andra AP fonden Increases Stock Holdings in Avantor, Inc. (NYSE:AVTR)

Andra AP fonden grew its position in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 50.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 332,202 shares of the company's stock after purchasing an additional 110,664 shares during the period. Andra AP fonden's holdings in Avantor were worth $6,999,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the company. State Street Corp lifted its stake in shares of Avantor by 58.0% in the 3rd quarter. State Street Corp now owns 22,368,244 shares of the company's stock valued at $578,666,000 after purchasing an additional 8,206,695 shares during the last quarter. Janus Henderson Group PLC boosted its stake in Avantor by 18.2% during the third quarter. Janus Henderson Group PLC now owns 17,692,705 shares of the company's stock worth $457,710,000 after buying an additional 2,719,615 shares during the period. Geode Capital Management LLC increased its position in Avantor by 7.1% during the third quarter. Geode Capital Management LLC now owns 11,150,788 shares of the company's stock valued at $287,791,000 after acquiring an additional 739,667 shares during the last quarter. Robeco Schweiz AG raised its stake in shares of Avantor by 12.5% in the fourth quarter. Robeco Schweiz AG now owns 7,612,555 shares of the company's stock valued at $160,397,000 after acquiring an additional 848,814 shares during the period. Finally, The Manufacturers Life Insurance Company lifted its holdings in shares of Avantor by 653.0% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 6,174,736 shares of the company's stock worth $159,740,000 after acquiring an additional 5,354,678 shares during the last quarter. 95.08% of the stock is owned by institutional investors.

Remove Ads

Insider Buying and Selling

In other Avantor news, CAO Steven W. Eck sold 4,907 shares of the business's stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total transaction of $86,019.71. Following the sale, the chief accounting officer now owns 40,604 shares of the company's stock, valued at approximately $711,788.12. The trade was a 10.78 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP James Bramwell sold 3,758 shares of the firm's stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $65,877.74. Following the completion of the transaction, the executive vice president now owns 87,379 shares of the company's stock, valued at $1,531,753.87. This trade represents a 4.12 % decrease in their position. The disclosure for this sale can be found here. 1.50% of the stock is owned by company insiders.

Avantor Stock Down 6.6 %

NYSE AVTR traded down $1.13 during midday trading on Wednesday, hitting $15.81. 10,885,416 shares of the company traded hands, compared to its average volume of 6,658,394. The company's 50-day simple moving average is $19.83 and its 200-day simple moving average is $22.21. Avantor, Inc. has a 52 week low of $15.37 and a 52 week high of $28.00. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.07 and a quick ratio of 0.70. The company has a market cap of $10.76 billion, a PE ratio of 15.20, a price-to-earnings-growth ratio of 1.55 and a beta of 1.30.

Avantor (NYSE:AVTR - Get Free Report) last posted its earnings results on Wednesday, February 12th. The company reported $0.27 EPS for the quarter, beating analysts' consensus estimates of $0.26 by $0.01. Avantor had a net margin of 10.49% and a return on equity of 12.17%. During the same quarter in the previous year, the business earned $0.22 earnings per share. As a group, equities research analysts forecast that Avantor, Inc. will post 1.06 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on AVTR. Barclays reduced their price target on Avantor from $26.00 to $23.00 and set an "overweight" rating on the stock in a report on Monday, February 10th. Morgan Stanley reduced their target price on Avantor from $27.00 to $25.00 and set an "overweight" rating on the stock in a research note on Monday, February 10th. Wells Fargo & Company lowered their target price on shares of Avantor from $28.00 to $25.00 and set an "overweight" rating for the company in a research note on Monday, February 10th. UBS Group reaffirmed a "neutral" rating and issued a $25.00 price target (down previously from $29.00) on shares of Avantor in a research note on Friday, January 17th. Finally, Royal Bank of Canada lowered their price objective on shares of Avantor from $33.00 to $31.00 and set an "outperform" rating for the company in a research report on Monday, February 10th. Three investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company's stock. According to data from MarketBeat, Avantor has an average rating of "Moderate Buy" and an average price target of $25.50.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.